GECROL

Prophylaxis and treatment of transplant rejection in allograft recipients

QUALITATIVE AND QUANTITATIVE COMPOSITION

GECROL 1 mg contains 1 mg tacrolimus Excipient with known effect: lactose 108.6 mg.
GECROL 5 mg contains 5 mg tacrolimus Excipient with known effect: lactose 104.6 mg.

THERAPEUTIC INDICATIONS

GECROL is indicated in children and adults for the prophylaxis of transplant rejection in recipients of liver, kidney or heart allogeneic graft.

Treatment is used in case of allograft rejection resistant to treatment with other immunosuppressive medical products.

DISPENSING AND REIMBURSEMENT

Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.

Mandatory information